Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CATHY B BARNES

Allopathic & Osteopathic Physicians Family Medicine

NPI
1821089756
CMS profile
309044
Location
TRINITY, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$102.51

1 record · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $102.51 1

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Janssen Pharmaceuticals, Inc $102.51 1

Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CATHY B BARNES

NPI 1821089756 · CMS profile ID 309044

Allopathic & Osteopathic Physicians / Family Medicine

TRINITY, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1821089756?year=2021&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CATHY B BARNES, NPI 1821089756, CMS profile ID 309044. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1821089756?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). CATHY B BARNES, NPI 1821089756, CMS profile ID 309044. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1821089756?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
CATHY B BARNES, NPI 1821089756, CMS profile ID 309044, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1821089756?year=2021&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

1 matching record · $102.51 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 1 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–1 of 1.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Janssen Pharmaceuticals, Inc $102.5110/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788717037 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $242.96 3
PY2020 $2,414.87 43
PY2021 $102.51 1
PY2022 $81.28 1
PY2024 $1,292.30 10
PY2025 $1,335.09 13

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $3,205,743.80 119
PY2024 Recipient $34,906.00 2
PY2024 Principal investigator $2,451,942.71 49
PY2023 Recipient $2,790.56 3
PY2023 Principal investigator $2,713,362.43 33
PY2022 Recipient $28,555.00 4
PY2022 Principal investigator $1,298,287.06 112
PY2021 Principal investigator $858,224.34 839
PY2020 Recipient $142.50 1
PY2020 Principal investigator $353,224.47 119
PY2019 Recipient $12,826.75 13
PY2019 Principal investigator $389,491.61 41

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

120 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $4,040.94 12/31/2020 Non-covered Recipient Entity
Suncoast Clinical Research
A Long Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs with Hypertriglyceridemia No dispute reported 06/30/2026 736743109
Principal investigator 1 Novo Nordisk AS $2,500.00 12/22/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361785
Principal investigator 1 Novo Nordisk AS $1,000.00 12/22/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361787
Principal investigator 1 SANOFI US SERVICES INC. $3,250.00 12/21/2020 Non-covered Recipient Entity
Suncoast Clinical Research Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk No dispute reported 06/30/2026 744053821
Principal investigator 1 Novo Nordisk AS $118.00 12/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 822167497
Principal investigator 1 Novo Nordisk AS $118.00 12/15/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 822167495
Principal investigator 1 SANOFI US SERVICES INC. $7,400.00 11/23/2020 Non-covered Recipient Entity
Suncoast Clinical Research Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk No dispute reported 06/30/2026 744053797
Principal investigator 1 Novo Nordisk AS $0.30 11/20/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361493
Principal investigator 1 Novo Nordisk AS $5.72 11/20/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361495
Principal investigator 1 Novo Nordisk AS $325.80 11/20/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361497
Principal investigator 1 Novo Nordisk AS $891.00 11/20/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361499
Principal investigator 1 Novo Nordisk AS $439.20 11/20/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361501
Principal investigator 1 AbbVie Inc. $429.00 11/19/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
M15-999 No dispute reported 06/30/2026 721196321
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361605
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361607
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361609
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361611
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361613
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361615
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361617
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361619
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361621
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361623
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361625
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361627
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361629
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361631
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361633
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361635
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361637
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361639
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361641
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361643
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361645
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361647
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361649
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361651
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361653
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361655
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361657
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361659
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361661
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361663
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361665
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361667
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361669
Principal investigator 1 Novo Nordisk AS $3.05 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361671
Principal investigator 1 Novo Nordisk AS $1.95 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361673
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361675
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361677
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361679
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361681
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361683
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361685
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361687
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361689
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361691
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361693
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361695
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361697
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361699
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361701
Principal investigator 1 Novo Nordisk AS $9.98 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361703
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361705
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361707
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361709
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361711
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361713
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361715
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361717
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361719
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361721
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361723
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361725
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361727
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361729
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361731
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361733
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361735
Principal investigator 1 Novo Nordisk AS $5.30 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361737
Principal investigator 1 Novo Nordisk AS $3.02 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361739
Principal investigator 1 Novo Nordisk AS $22.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361741
Principal investigator 1 Novo Nordisk AS $8.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361743
Principal investigator 1 Novo Nordisk AS $72.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361745
Principal investigator 1 Novo Nordisk AS $3.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361747
Principal investigator 1 Novo Nordisk AS $39.90 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361749
Principal investigator 1 Novo Nordisk AS $6.50 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361751
Principal investigator 1 Novo Nordisk AS $9.74 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361753
Principal investigator 1 Novo Nordisk AS $40.00 11/17/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361755
Principal investigator 1 Novo Nordisk AS $562.00 11/06/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361799
Principal investigator 1 Novo Nordisk AS $1,182.00 11/06/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
NN1436-4477 No dispute reported 06/30/2026 742361801
Principal investigator 1 Eli Lilly and Company $50,074.00 10/27/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
A PHASE 2, PARALLEL, COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN INSULIN NAIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 728747549
Principal investigator 1 SANOFI US SERVICES INC. $4,190.00 10/26/2020 Non-covered Recipient Entity
Suncoast Clinical Research Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk No dispute reported 06/30/2026 744053763
Principal investigator 1 Abbott Laboratories $33,697.50 10/22/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH, INC.
ID NOW COVID-19 No dispute reported 06/30/2026 749809397
Principal investigator 1 Abbott Laboratories $20,000.00 10/22/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH, INC.
ID NOW COVID-19 No dispute reported 06/30/2026 749809401
Principal investigator 1 Akcea Therapeutics, Inc. $3,546.20 09/29/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH INC
A Randomized, Double-blind, Placebo-Controlled, Dose-Ranging Phase 2 Study of ISIS 678354 Administered Subcutaneously to Patients With Hypertriglyceridemia and Established Cardiovascular Disease (CVD) or at a High Risk for CVD No dispute reported 06/30/2026 750821053
Principal investigator 1 SANOFI US SERVICES INC. $3,520.00 09/28/2020 Non-covered Recipient Entity
Suncoast Clinical Research Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk No dispute reported 06/30/2026 744053771
Principal investigator 1 SANOFI US SERVICES INC. $2,129.00 09/02/2020 Non-covered Recipient Entity
Suncoast Clinical Research Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk No dispute reported 06/30/2026 744053777
Principal investigator 1 SANOFI US SERVICES INC. $3,477.00 08/04/2020 Non-covered Recipient Entity
Suncoast Clinical Research Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk No dispute reported 06/30/2026 744053757
Recipient Eli Lilly and Company $142.50 07/31/2020 Covered Recipient Physician A PHASE 2, PARALLEL, COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN INSULIN NAIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 728718041
Principal investigator 1 SANOFI US SERVICES INC. $53,252.00 07/20/2020 Non-covered Recipient Entity
Suncoast Clinical Research Inc
Randomized, Open Label, Parallel-group Study Comparing the Pharmacokinetics and Immunogenicity of Alternating Use of SAR341402 and NovoLog Versus Continuous Use of NovoLog in Participants With Type 1 Diabetes Mellitus Also Using Insulin Glargine No dispute reported 06/30/2026 744053749
Principal investigator 1 SANOFI US SERVICES INC. $2,118.00 06/29/2020 Non-covered Recipient Entity
Suncoast Clinical Research Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk No dispute reported 06/30/2026 744053731
Principal investigator 1 SANOFI US SERVICES INC. $1,776.00 06/29/2020 Non-covered Recipient Entity
Suncoast Clinical Research Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk No dispute reported 06/30/2026 744053739
Principal investigator 1 AbbVie Inc. $2,091.30 06/22/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
M15-999 No dispute reported 06/30/2026 721171807
Principal investigator 1 SANOFI US SERVICES INC. $5,352.00 06/15/2020 Non-covered Recipient Entity
Suncoast Clinical Research Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk No dispute reported 06/30/2026 744053719
Principal investigator 1 AbbVie Inc. $2,668.50 04/21/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
M15-999 No dispute reported 06/30/2026 721161543
Principal investigator 1 SANOFI US SERVICES INC. $22,759.00 04/20/2020 Non-covered Recipient Entity
Suncoast Clinical Research Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk No dispute reported 06/30/2026 744053681
Principal investigator 1 AbbVie Inc. $2,078.30 03/19/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
M15-999 No dispute reported 06/30/2026 721156291
Principal investigator 1 SANOFI US SERVICES INC. $40,371.00 03/09/2020 Non-covered Recipient Entity
Suncoast Clinical Research Inc
Randomized, Open Label, Parallel-group Study Comparing the Pharmacokinetics and Immunogenicity of Alternating Use of SAR341402 and NovoLog Versus Continuous Use of NovoLog in Participants With Type 1 Diabetes Mellitus Also Using Insulin Glargine No dispute reported 06/30/2026 744053649
Principal investigator 1 Eli Lilly and Company $6,463.60 03/06/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
A PHASE 2, PARALLEL, COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN INSULIN NAIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 728739609
Principal investigator 1 AbbVie Inc. $750.00 03/05/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
M15-999 No dispute reported 06/30/2026 721154633
Principal investigator 1 SANOFI US SERVICES INC. $3,124.00 03/03/2020 Non-covered Recipient Entity
Suncoast Clinical Research Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk No dispute reported 06/30/2026 744053637
Principal investigator 1 Akcea Therapeutics, Inc. $578.00 02/24/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH INC
A Randomized, Double-blind, Placebo-Controlled, Dose-Ranging Phase 2 Study of ISIS 678354 Administered Subcutaneously to Patients With Hypertriglyceridemia and Established Cardiovascular Disease (CVD) or at a High Risk for CVD No dispute reported 06/30/2026 750820621
Principal investigator 1 AbbVie Inc. $972.00 02/20/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
M15-999 No dispute reported 06/30/2026 721151511
Principal investigator 1 SANOFI US SERVICES INC. $17,879.00 02/10/2020 Non-covered Recipient Entity
Suncoast Clinical Research Inc
Randomized, Open Label, Parallel-group Study Comparing the Pharmacokinetics and Immunogenicity of Alternating Use of SAR341402 and NovoLog Versus Continuous Use of NovoLog in Participants With Type 1 Diabetes Mellitus Also Using Insulin Glargine No dispute reported 06/30/2026 744053627
Principal investigator 1 Akcea Therapeutics, Inc. $9,259.90 01/30/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH INC
A Randomized, Double-blind, Placebo-Controlled, Dose-Ranging Phase 2 Study of ISIS 678354 Administered Subcutaneously to Patients With Hypertriglyceridemia and Established Cardiovascular Disease (CVD) or at a High Risk for CVD No dispute reported 06/30/2026 750820257
Principal investigator 1 SANOFI US SERVICES INC. $7,440.00 01/27/2020 Non-covered Recipient Entity
Suncoast Clinical Research Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk No dispute reported 06/30/2026 744053609
Principal investigator 1 AstraZeneca Pharmaceuticals LP $25,457.90 01/24/2020 Non-covered Recipient Entity
Suncoast Clinical Research
A Long Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs with Hypertriglyceridemia No dispute reported 06/30/2026 736739391
Principal investigator 1 AbbVie Inc. $3,640.50 01/21/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
M15-999 No dispute reported 06/30/2026 721146201
Principal investigator 1 Eli Lilly and Company $1,785.00 01/07/2020 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
A 24-WEEK MULTICENTER, RANDOMIZED, BLINDED, PARALLEL-GROUP STUDY COMPARING THE EFFICACY AND SAFETY OF IXEKIZUMAB TO GUSELKUMAB IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS No dispute reported 06/30/2026 728745579